Cargando…

Immune-modulatory Properties of the Octapeptide NAP in Campylobacter jejuni Infected Mice Suffering from Acute Enterocolitis

Human infections with the food-borne zoonotic pathogen Campylobacter jejuni are progressively rising and constitute serious global public health and socioeconomic burdens. Hence, application of compounds with disease-alleviating properties are required to combat campylobacteriosis and post-infectiou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heimesaat, Markus M., Mousavi, Soraya, Kløve, Sigri, Genger, Claudia, Weschka, Dennis, Giladi, Eliezer, Bereswill, Stefan, Gozes, Illana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356963/ https://www.ncbi.nlm.nih.gov/pubmed/32466564 http://dx.doi.org/10.3390/microorganisms8060802

Ejemplares similares

Pituitary Adenylate Cyclase-Activating Polypeptide Alleviates Intestinal, Extra-Intestinal and Systemic Inflammatory Responses during Acute Campylobacter jejuni-induced Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis
por: Escher, Ulrike, et al.
Publicado: (2018)

The Host-Specific Intestinal Microbiota Composition Impacts Campylobacter coli Infection in a Clinical Mouse Model of Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Toll-Like Receptor-4 Is Involved in Mediating Intestinal and Extra-Intestinal Inflammation in Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice
por: Kløve, Sigri, et al.
Publicado: (2020)

Toll-Like Receptor-4 Dependent Intestinal and Systemic Sequelae Following Peroral Campylobacter coli Infection of IL10 Deficient Mice Harboring a Human Gut Microbiota
por: Kløve, Sigri, et al.
Publicado: (2020)

Inflammatory Immune Responses and Gut Microbiota Changes Following Campylobacter coli Infection of IL-10(-/-) Mice with Chronic Colitis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
por: GENGER, CLAUDIA, et al.
Publicado: (2020)

Treatment with the Probiotic Product Aviguard(®) Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(®) to microbiota-depleted wildtype mice
por: HEIMESAAT, MARKUS M., et al.
Publicado: (2020)

Vitamin C alleviates acute enterocolitis in Campylobacter jejuni infected mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Campylobacter jejuni infection induces acute enterocolitis in IL-10(-/-) mice pretreated with ampicillin plus sulbactam
por: Heimesaat, Markus M., et al.
Publicado: (2022)

Preclinical Evaluation of Oral Urolithin-A for the Treatment of Acute Campylobacteriosis in Campylobacter jejuni Infected Microbiota-Depleted IL-10(−/−) Mice
por: Mousavi, Soraya, et al.
Publicado: (2020)

Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond
por: Kapitansky, Oxana, et al.
Publicado: (2020)

Immune-Modulatory Effects upon Oral Application of Cumin-Essential-Oil to Mice Suffering from Acute Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2021)

Survey of Pathogen-Lowering and Immuno-Modulatory Effects Upon Treatment of Campylobacter coli-Infected Secondary Abiotic IL-10(−/−) Mice with the Probiotic Formulation Aviguard(®)
por: Weschka, Dennis, et al.
Publicado: (2021)

Iron Deprivation by Oral Deferoxamine Application Alleviates Acute Campylobacteriosis in a Clinical Murine Campylobacter jejuni Infection Model
por: Bereswill, Stefan, et al.
Publicado: (2022)

Anti-Pathogenic and Immune-Modulatory Effects of Peroral Treatment with Cardamom Essential Oil in Acute Murine Campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Resveratrol Alleviates Acute Campylobacter jejuni Induced Enterocolitis in a Preclinical Murine Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Vitamin D in Acute Campylobacteriosis–Results From an Intervention Study Applying a Clinical Campylobacter jejuni Induced Enterocolitis Model
por: Mousavi, Soraya, et al.
Publicado: (2019)

Human microbiota associated IL-10(−/−) mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
por: Shayya, Nizar W., et al.
Publicado: (2023)

Risperidone and NAP protect cognition and normalize gene expression in a schizophrenia mouse model
por: Vaisburd, Sinaya, et al.
Publicado: (2015)

Novel Clinical Campylobacter jejuni Infection Models Based on Sensitization of Mice to Lipooligosaccharide, a Major Bacterial Factor Triggering Innate Immune Responses in Human Campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2020)

Anti-Inflammatory Properties of NAP in Acute Toxoplasma Gondii-Induced Ileitis in Mice
por: Heimesaat, Markus M., et al.
Publicado: (2015)

Less Pronounced Immunopathological Responses Following Oral Butyrate Treatment of Campylobacter jejuni-Infected Mice
por: Du, Ke, et al.
Publicado: (2022)

The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse
por: Sragovich, Shlomo, et al.
Publicado: (2019)

Campylobacter concisus Impairs Sodium Absorption in Colonic Epithelium via ENaC Dysfunction and Claudin-8 Disruption
por: Nattramilarasu, Praveen Kumar, et al.
Publicado: (2020)

Immunopathological properties of the Campylobacter jejuni flagellins and the adhesin CadF as assessed in a clinical murine infection model
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Campylobacter jejuni Induces Acute Enterocolitis in Gnotobiotic IL-10(−/−) Mice via Toll-Like-Receptor-2 and -4 Signaling
por: Haag, Lea-Maxie, et al.
Publicado: (2012)

Disease-Alleviating Effects of Peroral Activated Charcoal Treatment in Acute Murine Campylobacteriosis
por: Bereswill, Stefan, et al.
Publicado: (2021)

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study
por: Heimesaat, Markus M., et al.
Publicado: (2021)

Disease alleviating effects following prophylactic lemon and coriander essential oil treatment in mice with acute campylobacteriosis
por: Mousavi, Soraya, et al.
Publicado: (2023)

Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2023)

Vitamin D Reverses Disruption of Gut Epithelial Barrier Function Caused by Campylobacter jejuni
por: Lobo de Sá, Fábia D., et al.
Publicado: (2021)

The ADNP Syndrome and CP201 (NAP) Potential and Hope
por: Gozes, Illana
Publicado: (2020)

Peptidase PepP is a novel virulence factor of Campylobacter jejuni contributing to murine campylobacteriosis
por: Heimesaat, Markus M., et al.
Publicado: (2020)

Protease Activity of Campylobacter jejuni HtrA Modulates Distinct Intestinal and Systemic Immune Responses in Infected Secondary Abiotic IL-10 Deficient Mice
por: Schmidt, Anna-Maria, et al.
Publicado: (2019)

Curcumin Mitigates Immune-Induced Epithelial Barrier Dysfunction by Campylobacter jejuni
por: Lobo de Sá, Fábia Daniela, et al.
Publicado: (2019)

Relapse of acute myocarditis associated with Campylobacter jejuni enterocolitis
por: Yaita, Shizuka, et al.
Publicado: (2020)

The Role of Gelatinases in Campylobacter Jejuni Infection of Gnotobiotic Mice
por: Alutis, Marie E., et al.
Publicado: (2015)

Campylobacter jejuni infection of conventionally colonized mice lacking nucleotide-oligomerization-domain-2
por: Bereswill, Stefan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_chbot647h2h6dpsdkheh9klbbv